| | | I'll comment on Burry and his latest positions:
First of all, imo, Burry is no value investor. And that's reflected by the stocks in his portfolio, and their rapid turnover. If his picks are valuestocks, it's pretty hard to see how they are, given what my view of value stocks is. Others may have a different opinion.
Este Lauder. I looked previous quarter's listing. Stock looked overvalued; I passed. Burry selling down this quarter.
LULU. Not a value stock in my opinion, and I've not mentioned it here because of that. However, LULU hit a 12-mo low recently, and I bought a few shares, and a few more as it has continued to drop. Company, imo, is a high-end athletic retailer, and maybe there will be enough demand for its products that the stock might recover. I visited my local store recently on a weekday, and at least there were a few people shopping, everything looked nicely presented, and there were some clothes in the men's section that appealed to me, and I might return to buy.
REGN. Stock has dithered since the market lows of April. Analysts are pretty much positive on the stock. I've held a few shares since Covid, and recently decided to a add a bit more. Total is a small tracking position. While I can model a higher stock price for next year using past numbers and analysts estimated earnings, I've only a smidgen of knowledge of company's new upcoming drugs or of their major drugs coming off patent. For me, it's not a value stock. More like a time to either get out or add a little more and wait more.
MELI has always seemed too expensive for me. My mistake. Now too, possibly: I've no position.
UNH. Have held a position for many years. Cut back as stock has fallen. Maybe there's a recovery in future. I'll continue to hold on to what I have. (Edit. Ok, I see the UNH Buffett purchase now. I may start adding.)
BRKR looks terribly overvalued to me. Since beginning of year stock has been mostly dropping. I see Burry got out by April, and now is back in at lower price. His pal, Greenblatt is also in now with what looks to me like a very small amount.
As I have posted before, the companies that supply products and services to the pharma/drug industry have been hit because of government policies and cut backs on research. The stocks hit 12-mo lows, and now seem to be recovering somewhat. (Maybe they'll fall back? Who knows?). I have mentioned some that I have bought in a small basket as they've hit lows: BDX, IQV, etc. I see now that BRKR seems to be primarily in this business subsector too. ("Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions...). The stock's now up 10% from its 12-mo low. I'll make the bet (tracking position) that BRKR stock might revert to somewhere closer to where it's traded in past. Only buying because I hope this stock might be doing what other stocks here seem to be doing. (Note. I recognize that having a basket here of these particular stocks might mitigate a specific business risk with one company, but that here, maybe it actually concentrates risk overall, because all these stocks seem to be caught in the harsh spotlight of government policies.) |
|
